Skip to content

Preoperative training and nutrition in the 'Active Recovery' care pathway

Feasibility and preliminary effectiveness of a preoperative training and nutrition intervention in people with sarcopenic obesity who receive total hip or knee arthroplasty within the 'Actief Herstel' care pathway

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON28555
Enrollment
34
Registered
2020-01-13
Start date
2020-03-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with osteoarthritis and sarcopenic obesity

Interventions

The intervention group will follow a supervised (by a physiotherapist) exercise intervention of 6 weeks (twice a week) with progressive strength training and aerobic training. This will be combined wi

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: • scheduled for THA or TKA with a waiting period of minimal 6 weeks (which is the usual waiting period) • OA as reason for THA or TKA • Having obesity (BMI =30 kg/m2) • Having muscle weakness (Men: Hand Grip Strength (HGS) 15sec for five rises) 12 • Adequate cognitive functioning (the patient is capable to understand instructions and to per-form the screening) • Age 18 years or older

Exclusion criteria

Exclusion criteria: • Unable to understand Dutch • Patients diagnosed with dementia • Patients who are unable to exercise due to comorbidities/ contra-indications. Absolute con-tra-indications for exercise are listed in the Dutch guideline for OA 13 and in the ACSM's Guidelines for Exercise Testing and Prescription 14. See appendix 1 for additional information about contraindications and considerations when prescribing exercises to older people with comorbidity. • Patients with severe renal insufficiency or an eGFR<30 (estimated Glomerular Filtration Rate)

Design outcomes

Primary

MeasureTime frame
Feasibility is assessed by adherence to the treatment, inclusion and dropout rate, adverse events and the patient appreciation and motivation, as assessed by questionnaires.

Secondary

MeasureTime frame
Preliminary effectiveness is assessed by measuring physical functioning (timed up and go test, hand grip strength, walking speed/ six-minute walk test, chair rise time test, questionnaires), body composition (BIA/ DEXA) and inflammation (CRP, IL-6) before and after 6 weeks of intervention. In addition, postoperative inpatient complications, recovery of physical functioning and length of hospital stay will be assessed. Furthermore, nutritional intake (3-day food diary) and physical activity (by accelerometer) will be measured.

Contacts

Public ContactEllen Oosting

Gelderse Vallei Hoispital

oostinge@zgv.nl+31318433799

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)